Enriched CD161high CCR6+γδt cells in the cerebrospinal fluid of patients with multiple sclerosis

JAMA Neurology

Volumn 70, Issue 3, 2013, Pages 345-351

  Schirmer, Lucas ^a   Rothhammer, Veit ^a   Hemmer, Bernhard ^a   Korn, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; BIOLOGICAL MARKER; CCR6 PROTEIN, HUMAN; KLRB1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; LYMPHOCYTE COUNT; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECURRENT DISEASE; STAINING; TERTIARY HEALTH CARE; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CCR6; T-LYMPHOCYTE SUBSETS;

MLCS; MLOWN;

EID: 84874864228     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamaneurol.409     Document Type: Article

References (28)

1. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485-517.
2. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain. 2009;132(pt 12):3329-3341.
3. Korn T, Petermann F. Development and function of interleukin 17-producing T cells. Ann N Y Acad Sci. 2012;1247(Jan):34-45.
4. Ribot JC, deBarros A, Pang DJ, et al. CD27 is a thymic determinant of the balance between interferon-gammaand interleukin 17-producing gammadelta T cell subsets. Nat Immunol. 2009;10(4):427-436.
5. Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci U S A. 1992;89(10):4588-4592.
6. Selmaj K, Brosnan CF, Raine CS. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65- oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A. 1991;88(15):6452-6456.
7. Poggi A, Zocchi MR, Costa P, et al. IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2-TCR gamma delta- T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol. 1999;162(7):4349-4354.
8. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009;31(2):321-330.
9. Hayday AC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity. 2009;31(2):184-196.
10. Kenna TJ, Davidson SI, Duan R, et al. Enrichment of circulating IL-17-secreting IL-23 receptor-positive gammadelta T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012;64(5):1420-1429.
11. Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL-17-producing T cells in skin inflammation. Immunity. 2011;35(4):596-610.
12. CosmiL,DePalmaR, Santarlasci V, et al.Humaninterleukin 17-producing cells originate from a CD161-CD4-T cell precursor. J ExpMed. 2008;205(8):1903-1916.
13. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8(6):639-646.
14. Petermann F, Rothhammer V, Claussen MC, et al. T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23dependent mechanism. Immunity. 2010;33(3):351-363.
15. Cairo C, Armstrong CL, Cummings JS, et al. Impact of age, gender, and race on circulating T cells. Hum Immunol. 2010;71(10):968-975.
16. Michishita Y, Hirokawa M, Guo YM, et al. Age-associated alteration of T-cell repertoire and different profiles of activation-induced death of V-1 and V-2 T cells. Int J Hematol. 2011;94(3):230-240.
17. Turchinovich G, Hayday AC. Skint-1 identifies a common molecular mechanism for the development of interferon-secreting versus interleukin-17-secreting T cells. Immunity. 2011;35(1):59-68.
18. Haas JD, González FH, Schmitz S, et al. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Eur J Immunol. 2009;39(12):3488-3497.
19. Haas JD, Ravens S, Duber S, et al. Development of interleukin-17- producing T cells is restricted to a functional embryonic wave. Immunity. 2012;37(1):48-59.
20. Caccamo N, LaMendola C, Orlando V, et al. Differentiation, phenotype, and function of interleukin-17-producing human V-9V-2 T cells. Blood. 2011;118(1): 129-138.
21. Peng MY, Wang ZH, Yao CY, et al. Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol. 2008; 5(3):203-208.
22. McGeachy MJ, Chen Y, Tato CM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. 2009;10(3):314-324.
23. Maggi L, Santarlasci V, Capone M, et al. CD161 is a marker of all human IL-17producing T-cell subsets and is induced by RORC. Eur J Immunol. 2010;40 (8):2174-2181.
24. Annibali V, Ristori G, Angelini DF, et al. CD161(high)CD8-T cells bear pathogenetic potential in multiple sclerosis. Brain. 2011;134(pt 2):542-554.
25. Rosen DB, Cao W, Avery DT, et al. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol. 2008;180(10):6508-6517.
26. Kleinschek MA, Boniface K, Sadekova S, et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med. 2009;206(3):525-534.
27. Hafler DA, Compston A, Sawcer S, et al International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357(9):851-862.
28. Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10(5):514-523.